Suspension of Sales Clause Example from Business Contracts

This example Suspension of Sales clause appears in 13 contracts from 12 companies

Suspension of Sales. (a) The Company or HCW may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on Schedule 2, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on Schedule 2), suspend any ...sale of Placement Shares; provided, however, that such suspension shall not affect or impair either party's obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. Each of the parties agrees that no such notice under this Section 4 shall be effective against the other unless it is made to one of the individuals named on Schedule 2 hereto, as such schedule may be amended from time to time and in accordance with the notice delivery requirements of this Section 4. While a suspension is in effect, any obligation under Sections 7(m), 7(n), and 7(o) with respect to the delivery of certificates, opinions, or comfort letters to HCW shall be deemed waived. (b) Notwithstanding any other provision of this Agreement, during any period in which the Company is in possession of material non-public information, the Company and HCW agree that (i) no sale of Placement Shares will take place, (ii) the Company shall not request the sale of any Placement Shares, and (iii) HCW shall not be obligated to sell or offer to sell any Placement Shares. View More Arrow
Found in Cyclacel Pharmaceuticals, Inc. contract
AGILE THERAPEUTICS INC Contracts

Common Stock Sales Agreement dated January 23, 2019 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 23, 2019)

Common Stock Sales Agreement dated November 8, 2019 by and between Agile Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on November 8, 2019)

aTYR PHARMA INC Contracts

Common Stock Sales Agreement, dated May 21, 2019, between the Registrant and H.C. Wainwright & Co., LLC (Filed With SEC on May 22, 2019)

Flux Power Holdings, Inc. Contracts

Sales Agreement with H.C. Wainwright & Co., LLC (Filed With SEC on December 21, 2020)

Cyclacel Pharmaceuticals, Inc. Contracts

Common Stock Sales Agreement, dated October 4, 2018, by and between Cyclacel Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 4, 2018)

ReShape Lifesciences Inc. Contracts

Sales Agreement, dated October 2, 2018, by and between ReShape Lifesciences Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 3, 2018)

XOMA Corp Contracts

Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on December 18, 2018)

Isoray, Inc. Contracts

Sales Agreement between IsoRay, Inc. and H.C. Wainwright & Co., LLC, dated May 8, 2018 (Filed With SEC on May 8, 2018)

Dare Bioscience, Inc. Contracts

Common Stock Sales Agreement, dated January 4, 2018, by and between Dar Bioscience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 4, 2018)

CALADRIUS BIOSCIENCES, INC. Contracts

Common Stock Sales Agreement, dated February 8, 2018, by and between Caladrius Biosciences, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 8, 2018)

CASI Pharmaceuticals, Inc. Contracts

Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated February 23, 2018 (Filed With SEC on February 23, 2018)

MYOS RENS TECHNOLOGY INC. Contracts

MYOSRENS TECHNOLOGy inc. $6,000,000 cOMMONSTOCK SALESAGREEMENT (Filed With SEC on February 21, 2017)

ALIMERA SCIENCES INC Contracts

Common Stock Sales Agreement by and between Alimera Sciences, Inc. and H.C. Wainwright & Co., LLC dated October 20, 2017 (Filed With SEC on October 20, 2017)